Safety and Tolerability of the Toll-Like Receptor (TLR)2/6 Agonist INNA-051 in Healthy Adults

被引：0
|
作者：
White, S. [1 ]
Lemech, C. [2 ]
Hari, R. [2 ]
Kruger, N. [1 ]
McLachlan, G. [1 ]
Demaison, C. [1 ]
Mercuri, F. [1 ]
机构：
[1] Ena Resp, Sydney, NSW, Australia
[2] Scientia Clin Res Ltd, Randwick, NSW, Australia
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2598
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evaluation of intranasal TLR2/6 agonist INNA-051: safety,tolerability and proof of pharmacology
    Mercuri, Francesca A.
    White, Scott
    Mcquilten, Hayley A.
    Lemech, Charlotte
    Mynhardt, Stephan
    Hari, Rana
    Zhang, Ping
    Kruger, Nicole
    Mclachlan, Grant
    Miller, Bruce E.
    West, Nicholas P.
    Tal-Singer, Ruth
    Demaison, Christophe
    ERJ OPEN RESEARCH, 2024, 10 (06)
  • [2] Development of TLR2/6 Agonist (INNA-051) to Protect the Elderly Against Respiratory Virus Infection
    Anderson, G. P.
    Jarnicki, A.
    Loo, S.
    Ciccotosto, J.
    Girkin, J.
    O'Donoghue, R.
    Mercuri, F.
    Bartlett, N. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [3] Discovery and development of INNA-051, a TLR2/6 agonist for the prevention of complications resulting from viral respiratory infections
    Mercuri, Francesca A.
    Anderson, Gary P.
    Miller, Bruce E.
    Demaison, Christophe
    Tal-Singer, Ruth
    ANTIVIRAL RESEARCH, 2025, 234
  • [4] The effect of toll-like receptor (TLR)-2 agonist PamCys in pneumococcal meningitis
    Sellner, J.
    Gianinazzi, C.
    Landmann, R.
    Leib, S. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 33 - 33
  • [5] Structural characterisation of Toll-like receptor 1 (TLR1) and Toll-like receptor 6 (TLR6) in elephant and harbor seals
    Woodman, Sally
    Gibson, Amanda J.
    Garcia, Ana Rubio
    Contreras, Guillermo Sanchez
    Rossen, John W.
    Werling, Dirk
    Offord, Victoria
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2016, 169 : 10 - 14
  • [6] First in Human Study of GS-9688, an Oral Toll-like Receptor 8 (TLR8) Agonist, in Healthy Volunteers: Assessment of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect
    Reyes, Maribel
    Lutz, Justin D.
    Lau, Audrey H.
    Gaggar, Anuj
    Grant, Ethan
    Joshi, Adarsh
    Mackman, Richard L.
    Ling, John
    Mathias, Anita
    German, Polina
    Gane, Edward J.
    HEPATOLOGY, 2018, 68 : 233A - 233A
  • [7] Safety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands
    Alfaro, Victoria Y.
    Goldblatt, David L.
    Valverde, Gabriella R.
    Munsell, Mark F.
    Quinton, Lee J.
    Walker, Adam K.
    Dantzer, Robert
    Varadhachary, Atul
    Scott, Brenton L.
    Evans, Scott E.
    Tuvim, Michael J.
    Dickey, Burton F.
    FRONTIERS IN PHARMACOLOGY, 2014, 5
  • [8] A Toll-like receptor 3 (TLR3) agonist ARNAX for therapeutic immunotherapy
    Seya, Tsukasa
    Takeda, Yohei
    Matsumoto, Misako
    ADVANCED DRUG DELIVERY REVIEWS, 2019, 147 : 37 - 43
  • [9] Safety, pharmacokinetics and pharmacodynamics of TQ-A3334, an oral toll-like receptor 7 agonist in healthy individuals
    Hu, Yue
    Zhang, Hong
    Wu, Min
    Liu, Jingrui
    Li, Xiaojiao
    Zhu, Xiaoxue
    Li, Cuiyun
    Chen, Hong
    Liu, Chengjiao
    Niu, Junqi
    Ding, Yanhua
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (03) : 263 - 269
  • [10] Polymorphisms within the Toll-like receptor (TLR)-2,-4, and-6 genes in cattle
    Pariset, L.
    Mariotti, M.
    Marchitelli, C.
    Crisa, A.
    Napolitano, F.
    Failla, S.
    De Matteis, G.
    Valentini, A.
    ITALIAN JOURNAL OF ANIMAL SCIENCE, 2007, 6 : 182 - 182
12345